Correlation Between Dev Information and Aarey Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dev Information and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dev Information and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dev Information Technology and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on Dev Information and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dev Information with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dev Information and Aarey Drugs.

Diversification Opportunities for Dev Information and Aarey Drugs

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dev and Aarey is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Dev Information Technology and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and Dev Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dev Information Technology are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of Dev Information i.e., Dev Information and Aarey Drugs go up and down completely randomly.

Pair Corralation between Dev Information and Aarey Drugs

Assuming the 90 days trading horizon Dev Information Technology is expected to generate 1.67 times more return on investment than Aarey Drugs. However, Dev Information is 1.67 times more volatile than Aarey Drugs Pharmaceuticals. It trades about 0.31 of its potential returns per unit of risk. Aarey Drugs Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  13,353  in Dev Information Technology on August 28, 2024 and sell it today you would earn a total of  3,838  from holding Dev Information Technology or generate 28.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dev Information Technology  vs.  Aarey Drugs Pharmaceuticals

 Performance 
       Timeline  
Dev Information Tech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dev Information Technology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Dev Information displayed solid returns over the last few months and may actually be approaching a breakup point.
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Dev Information and Aarey Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dev Information and Aarey Drugs

The main advantage of trading using opposite Dev Information and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dev Information position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.
The idea behind Dev Information Technology and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites